Literature DB >> 3679186

Omenn's syndrome--pathologic arguments in favor of a graft versus host pathogenesis: a report of nine cases.

H Jouan1, F Le Deist, C Nezelof.   

Abstract

Histologic, histochemical, and histoenzymatic investigations of nine cases of Omenn's disease showed generalized lymphoid depletion, including B cells and all T-cell subpopulations; an apparent proliferation of alpha-naphthyl acetate esterase-, acid phosphatase-, OKM1-positive macrophages and T6 interdigitating cells; a thymic hypoplasia with arrest of hassallian epithelial maturation; starlike fibrinous deposits in the bone marrow; and extensive cutaneous lesions characterized by hyperkeratosis, apoptotic cell death associated with the intraepidermal presence of T4+ and T8+ cells, localized necrosis of the basement membrane, expression of Ia antigens by malpighian cells, and progressive loss of the T6+ Langerhans' cells. These lesions, mainly the skin and bone marrow changes, are reminiscent of those observed in acute graft versus host reaction. Although a blood chimerism has never been demonstrated, these pathologic observations support the hypothesis of graft versus host disease in a primary cellular immunodeficiency and the persistence of the proliferating maternal cells in the peripheral target organs.

Entities:  

Mesh:

Year:  1987        PMID: 3679186     DOI: 10.1016/s0046-8177(87)80376-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  An unusual concurrence of graft versus host disease caused by engraftment of maternal lymphocytes with DiGeorge anomaly.

Authors:  J G Ocejo-Vinyals; M J Lozano; P Sánchez-Velasco; J Escribano de Diego; J E Paz-Miguel; F Leyva-Cobián
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

2.  Oligoclonal expansion of CD45RO+ T lymphocytes in Omenn syndrome.

Authors:  T O Harville; D M Adams; T A Howard; R E Ware
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

3.  Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders.

Authors:  T Wada; K Takei; M Kudo; S Shimura; Y Kasahara; S Koizumi; K Kawa-Ha; Y Ishida; S Imashuku; H Seki; A Yachie
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

4.  Successful bone marrow transplantation and treatment of BCG infection in two patients with severe combined immunodeficiency.

Authors:  R S Heyderman; G Morgan; R J Levinsky; S Strobel
Journal:  Eur J Pediatr       Date:  1991-05       Impact factor: 3.183

5.  Expansion of CD3+CD4-CD8- T cell population expressing high levels of IL-5 in Omenn's syndrome.

Authors:  I Melamed; A Cohen; C M Roifman
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

6.  Omenn syndrome with mutation in RAG1 gene.

Authors:  I Cherkaoui Jaouad; K Ouldim; S Ali Ou Alla; Y Kriouile; A Villa; A Sefiani
Journal:  Indian J Pediatr       Date:  2008-11-15       Impact factor: 1.967

Review 7.  Lymph node pathology in primary combined immunodeficiency diseases.

Authors:  F Facchetti; L Blanzuoli; M Ungari; O Alebardi; W Vermi
Journal:  Springer Semin Immunopathol       Date:  1998
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.